Holen Sie sich die Stockscreener-App
0.0127
7.63%
0.0009
Schlusskurs vom Vortag:
$0.0118
Offen:
$0.0108
24-Stunden-Volumen:
271.10K
Relative Volume:
7.18
Marktkapitalisierung:
$N/A
Einnahmen:
$2.30M
Nettoeinkommen (Verlust:
$-14.73M
KGV:
-0.000342
EPS:
-37.0861
Netto-Cashflow:
$-4.50M
1W Leistung:
+8.36%
1M Leistung:
-56.06%
6M Leistung:
-99.44%
1J Leistung:
-99.75%
1-Tages-Spanne:
$0.0107
$0.0132
1-Wochen-Bereich:
$0.0107
$0.0132
52-Wochen-Spanne:
$0.0107
$0.031
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Vergleichen Sie PTPI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.0127 | 0 | 2.30M | -14.73M | -4.50M | -37.09 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Petros Pharmaceuticals Inc Aktie (PTPI) Neueste Nachrichten
Comparing Eagle Pharmaceuticals (NASDAQ:EGRX) & Petros Pharmaceuticals (NASDAQ:PTPI) - Defense World
Why Petros Pharmaceuticals Inc. stock is seen as undervaluedQuarterly Profit Review & Safe Entry Trade Reports - Newser
Downgrade Watch: Why Petros Pharmaceuticals Inc stock is seen as undervaluedWeekly Investment Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Will Petros Pharmaceuticals Inc. stock outperform Nasdaq indexQuarterly Earnings Report & Daily Technical Forecast Reports - BỘ NỘI VỤ
Why Petros Pharmaceuticals Inc. stock is considered a top pickTrade Risk Summary & Community Shared Stock Ideas - newser.com
Analyzing recovery setups for Petros Pharmaceuticals Inc. investors2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
What technical charts say about Petros Pharmaceuticals Inc. stockJuly 2025 Earnings & Smart Money Movement Alerts - newser.com
What catalysts could drive Petros Pharmaceuticals Inc. stock higherJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - newser.com
Ranking Petros Pharmaceuticals Inc. among high performing stocks via toolsTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
Is Petros Pharmaceuticals Inc. stock overvalued by current metricsEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Risk adjusted return profile for Petros Pharmaceuticals Inc. analyzedWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is Petros Pharmaceuticals Inc. stock attractive for long term wealth buildingJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com
Using portfolio simulators with Petros Pharmaceuticals Inc. included2025 Top Gainers & High Conviction Investment Ideas - newser.com
How supply chain issues affect Petros Pharmaceuticals Inc. stockFed Meeting & Technical Pattern Alert System - newser.com
Is Petros Pharmaceuticals Inc. stock bottoming outDollar Strength & Real-Time Market Trend Scan - newser.com
How to use a screener to detect Petros Pharmaceuticals Inc. breakoutsJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Price action breakdown for Petros Pharmaceuticals Inc.Weekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Why Petros Pharmaceuticals Inc. stock is a value investor pickShort Setup & Smart Investment Allocation Tips - Fundação Cultural do Pará
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Petros Pharmaceuticals, Inc. Quarterly Earnings Report | PTPI SEC FilingForm 10-Q - Stock Titan
Leading vs lagging indicators on Petros Pharmaceuticals Inc. performanceForecast Cut & High Accuracy Trade Alerts - newser.com
Technical signs of recovery in Petros Pharmaceuticals Inc.Market Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Petros Pharmaceuticals to be Delisted from Nasdaq - MSN
Real time social sentiment graph for Petros Pharmaceuticals Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Is Petros Pharmaceuticals Inc. stock supported by strong fundamentalsQuarterly Investment Review & Safe Entry Trade Reports - newser.com
Finanzdaten der Petros Pharmaceuticals Inc-Aktie (PTPI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.09%
Kapitalisierung:
|
Volumen (24h):